CA
KYNB

Cliff Asness’s Kyntra Bio KYNB Stock Holding History

Cliff Asness’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-52,835
Closed -$1.18M – 2799
2024
Q2 		$1.18M Buy
52,835
+30,784
+140% +$951K ﹤0.01% 1680
2024
Q1 		$1.3M Sell
22,051
-24,559
-53% -$1.06M ﹤0.01% 1586
2023
Q4 		$1.03M Buy
46,610
+12,059
+35% +$182K ﹤0.01% 1595
2023
Q3 		$745K Buy
34,551
+31,355
+981% +$1.23M ﹤0.01% 1714
2023
Q2 		$216K Buy
3,196
+2,517
+371% +$1.04M ﹤0.01% 2066
2023
Q1 		$317K Buy
+679
New +$359K ﹤0.01% 1927
2022
Q4 		– Sell
-1,611
Closed -$524K – 2226
2022
Q3 		$524K Buy
+1,611
New +$519K ﹤0.01% 1765
2022
Q2 		– Sell
-3,011
Closed -$905K – 2219
2022
Q1 		$905K Buy
+3,011
New +$1.05M ﹤0.01% 1590
2021
Q4 		– Sell
-3,083
Closed -$788K – 2223
2021
Q3 		$788K Buy
+3,083
New +$1.09M ﹤0.01% 1664
2021
Q1 		– Sell
-343
Closed -$318K – 2217
2020
Q4 		$318K Sell
343
-238
-41% -$250K ﹤0.01% 1948
2020
Q3 		$597K Sell
581
-1,564
-73% -$1.68M ﹤0.01% 1649
2020
Q2 		$2.17M Sell
2,145
-785
-27% -$729K ﹤0.01% 1123
2020
Q1 		$2.54M Sell
2,930
-950
-24% -$944K ﹤0.01% 996
2019
Q4 		$4.16M Buy
3,880
+3,217
+485% +$3.28M ﹤0.01% 1029
2019
Q3 		$613K Sell
663
-13
-2% -$14.3K ﹤0.01% 1684
2019
Q2 		$764K Buy
676
+437
+183% +$478K ﹤0.01% 1592
2019
Q1 		$325K Sell
239
-80
-25% -$108K ﹤0.01% 1946
2018
Q4 		$369K Sell
319
-1,454
-82% -$1.63M ﹤0.01% 1887
2018
Q3 		$2.69M Sell
1,773
-895
-34% -$1.38M ﹤0.01% 1263
2018
Q2 		$4.18M Sell
2,668
-2,425
-48% -$3.16M ﹤0.01% 1105
2018
Q1 		$5.88M Sell
5,093
-1,631
-24% -$2.15M 0.01% 939
2017
Q4 		$7.97M Buy
6,724
+388
+6% +$487K 0.01% 857
2017
Q3 		$8.52M Buy
6,336
+5,160
+439% +$5.44M 0.01% 838
2017
Q2 		$950K Buy
+1,176
New +$819K ﹤0.01% 1690

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Cliff Asness's KYNB Position: Q3 2024 in Review

Cliff Asness sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 52,835 shares — an estimated $1.18M sold.

Cliff Asness first reported a position in KYNB in Q2 2017 and held it in 24 quarters. The position peaked at $8.52M in Q3 2017. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Cliff Asness reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Cliff Asness sold 52,835 Kyntra Bio shares in Q3 2024, an estimated $1.18M.
  • Cliff Asness first reported a position in Kyntra Bio in Q2 2017 and held it in 24 quarters.
  • Cliff Asness's Kyntra Bio position peaked at $8.52M in Q3 2017.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on AQR Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.